Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352775 · ClinicalTrials.gov registry record · NA
Calcium Carbonate on Labor Induction
A NA study of Pregnancy and Uterine Contraction, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT06352775: Active NA study of Pregnancy and Uterine Contraction, sponsored by Wake Forest University Health Sciences.
NCT06352775 is a NA study of Pregnancy and Uterine Contraction that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 250 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06352775, a NA study of Pregnancy and Uterine Contraction, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to evaluate the safety and efficacy of administering calcium carbonate to laboring participants undergoing labor inductions. The investigators hypothesize that calcium carbonate is a low-risk preventative measure to decrease oxytocin induction time and dosage, decrease the rate of labor dystocia, decrease the rate of cesarean deliveries, and demonstrate no differences in maternal or neonatal safety outcomes.
Primary Outcome
Participants in the treatment group will have a shorter duration of induction with oxytocin than those in the retrospective historical control group.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Calcium Carbonate
Study Locations (1)
Wisconsin
- Aurora Sinai Medical Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT06352775 still lists
NCT06352775 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Calcium Carbonate is the first listed.
NCT06352775 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06352775 about?
NCT06352775 is a clinical study titled "Calcium Carbonate on Labor Induction". The investigators aim to evaluate the safety and efficacy of administering calcium carbonate to laboring participants undergoing labor inductions. The investigators hypothesize that calcium carbonate is a low-risk preventative measure to decrease oxytocin induction time and dosage, decrease the rate...
What is the current status of trial NCT06352775?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-06-01. Estimated completion is 2026-12-30.
What conditions does trial NCT06352775 study?
This clinical trial studies the following conditions: Pregnancy, Uterine Contraction.
What interventions are being tested in trial NCT06352775?
The interventions under investigation include: Calcium Carbonate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06352775?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06352775 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06352775's enrollment target sits among peer trials
250 80th of 191 higher than 112 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI